Literature DB >> 26914916

Impact of the papillary muscles on cardiac magnetic resonance image analysis of important left ventricular parameters in hypertrophic cardiomyopathy.

D H F Gommans1, J Bakker2, G E Cramer3, F W A Verheugt3, M A Brouwer3, M J M Kofflard4.   

Abstract

PURPOSE: The use of cardiac magnetic resonance (CMR) analysis has increased in patients with hypertrophic cardiomyopathy (HCM). Quantification of left ventricular (LV) measures will be affected by the inclusion or exclusion of the papillary muscles as part of the LV mass, but the magnitude of effect and potential consequences are unknown.
METHODS: We performed Cine-CMR in (1) clinical HCM patients (n = 55) and (2) subclinical HCM mutation carriers without hypertrophy (n = 14). Absolute and relative differences in LV ejection fraction (EF) and mass were assessed between algorithms with and without inclusion of the papillary muscles.
RESULTS: Papillary muscle mass in group 1 was 6.6 ± 2.5 g/m(2) and inclusion of the papillary muscles resulted in significant relative increases in LVEF of 4.5 ± 1.8 % and in LV mass of 8.7 ± 2.6 %. For group 2 these figures were 4.0 ± 0.9 g/m(2), 3.8 ± 1.0 % and 9.5 ± 1.8 %, respectively. With a coefficient of variation of 4 %, this 9 % difference in LV mass during CMR follow-up will be considered a change, while in fact the exact same mass may have been assessed according to two different algorithms.
CONCLUSIONS: In clinical HCM patients, CMR quantification of important LV measures is significantly affected by inclusion or exclusion of the papillary muscles. In relative terms, the difference was similar in subjects without hypertrophy. This underscores a general need for a uniform approach in CMR image analysis.

Entities:  

Keywords:  CMR; Cardiac magnetic resonance; Hypertrophic cardiomyopathy; Papillary muscles

Year:  2016        PMID: 26914916      PMCID: PMC4840113          DOI: 10.1007/s12471-016-0805-y

Source DB:  PubMed          Journal:  Neth Heart J        ISSN: 1568-5888            Impact factor:   2.380


  31 in total

1.  Which standard has the gold?

Authors:  C B Higgins
Journal:  J Am Coll Cardiol       Date:  1992-06       Impact factor: 24.094

2.  Impact of papillary muscles in ventricular volume and ejection fraction assessment by cardiovascular magnetic resonance.

Authors:  Burkhard Sievers; Simon Kirchberg; Asli Bakan; Ulrich Franken; Hans-Joachim Trappe
Journal:  J Cardiovasc Magn Reson       Date:  2004       Impact factor: 5.364

3.  Risk of sudden death in end-stage hypertrophic cardiomyopathy.

Authors:  Hirotaka Kawarai; Katsuya Kajimoto; Yuichiro Minami; Nobuhisa Hagiwara; Hiroshi Kasanuki
Journal:  J Card Fail       Date:  2011-03-25       Impact factor: 5.712

4.  Correlation of trabeculae and papillary muscles with clinical and cardiac characteristics and impact on CMR measures of LV anatomy and function.

Authors:  Michael L Chuang; Philimon Gona; Gilion L T F Hautvast; Carol J Salton; Susan J Blease; Susan B Yeon; Marcel Breeuwer; Christopher J O'Donnell; Warren J Manning
Journal:  JACC Cardiovasc Imaging       Date:  2012-11

5.  Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy.

Authors:  Carsten Rickers; Norbert M Wilke; Michael Jerosch-Herold; Susan A Casey; Prasad Panse; Neeta Panse; Jochen Weil; Andrey G Zenovich; Barry J Maron
Journal:  Circulation       Date:  2005-08-09       Impact factor: 29.690

6.  Effect of endocardial trabeculae on left ventricular measurements and measurement reproducibility at cardiovascular MR imaging.

Authors:  Theano Papavassiliu; Harald P Kühl; Meike Schröder; Tim Süselbeck; Olga Bondarenko; Christoph K Böhm; Aernout Beek; Mark M B Hofman; Albert C van Rossum
Journal:  Radiology       Date:  2005-06-13       Impact factor: 11.105

7.  Cardiovascular function in multi-ethnic study of atherosclerosis: normal values by age, sex, and ethnicity.

Authors:  Shunsuke Natori; Shenghan Lai; J Paul Finn; Antoinette S Gomes; W Gregory Hundley; Michael Jerosch-Herold; Gregory Pearson; Shantanu Sinha; Andrew Arai; Joao A C Lima; David A Bluemke
Journal:  AJR Am J Roentgenol       Date:  2006-06       Impact factor: 3.959

8.  Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy.

Authors:  Raymond H Chan; Barry J Maron; Iacopo Olivotto; Michael J Pencina; Gabriele Egidy Assenza; Tammy Haas; John R Lesser; Christiane Gruner; Andrew M Crean; Harry Rakowski; James E Udelson; Ethan Rowin; Massimo Lombardi; Franco Cecchi; Benedetta Tomberli; Paolo Spirito; Francesco Formisano; Elena Biagini; Claudio Rapezzi; Carlo Nicola De Cecco; Camillo Autore; E Francis Cook; Susie N Hong; C Michael Gibson; Warren J Manning; Evan Appelbaum; Martin S Maron
Journal:  Circulation       Date:  2014-08-05       Impact factor: 29.690

9.  Role of late gadolinium enhancement cardiovascular magnetic resonance in the risk stratification of hypertrophic cardiomyopathy.

Authors:  Tevfik F Ismail; Andrew Jabbour; Ankur Gulati; Amy Mallorie; Sadaf Raza; Thomas E Cowling; Bibek Das; Jahanzaib Khwaja; Francisco D Alpendurada; Ricardo Wage; Michael Roughton; William J McKenna; James C Moon; Amanda Varnava; Carl Shakespeare; Martin R Cowie; Stuart A Cook; Perry Elliott; Rory O'Hanlon; Dudley J Pennell; Sanjay K Prasad
Journal:  Heart       Date:  2014-06-24       Impact factor: 5.994

10.  Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular Magnetic Resonance (SCMR) board of trustees task force on standardized post processing.

Authors:  Jeanette Schulz-Menger; David A Bluemke; Jens Bremerich; Scott D Flamm; Mark A Fogel; Matthias G Friedrich; Raymond J Kim; Florian von Knobelsdorff-Brenkenhoff; Christopher M Kramer; Dudley J Pennell; Sven Plein; Eike Nagel
Journal:  J Cardiovasc Magn Reson       Date:  2013-05-01       Impact factor: 5.364

View more
  8 in total

1.  Characterization of Classical and Nonclassical Fabry Disease: A Multicenter Study.

Authors:  Maarten Arends; Christoph Wanner; Derralynn Hughes; Atul Mehta; Daniel Oder; Oliver T Watkinson; Perry M Elliott; Gabor E Linthorst; Frits A Wijburg; Marieke Biegstraaten; Carla E Hollak
Journal:  J Am Soc Nephrol       Date:  2016-12-15       Impact factor: 10.121

2.  Quantification of mitral regurgitation in patients with hypertrophic cardiomyopathy using aortic and pulmonary flow data: impacts of left ventricular outflow tract obstruction and different left ventricular segmentation methods.

Authors:  Mateusz Śpiewak; Mariusz Kłopotowski; Monika Gawor; Agata Kubik; Ewa Kowalik; Barbara Miłosz-Wieczorek; Maciej Dąbrowski; Konrad Werys; Łukasz Mazurkiewicz; Katarzyna Kożuch; Magdalena Polańska-Skrzypczyk; Joanna Petryka-Mazurkiewicz; Anna Klisiewicz; Zofia T Bilińska; Jacek Grzybowski; Adam Witkowski; Magdalena Marczak
Journal:  J Cardiovasc Magn Reson       Date:  2017-12-21       Impact factor: 5.364

3.  The demanding grey zone: Sport indices by cardiac magnetic resonance imaging differentiate hypertrophic cardiomyopathy from athlete's heart.

Authors:  Csilla Czimbalmos; Ibolya Csecs; Attila Toth; Orsolya Kiss; Ferenc Imre Suhai; Nora Sydo; Zsofia Dohy; Astrid Apor; Bela Merkely; Hajnalka Vago
Journal:  PLoS One       Date:  2019-02-14       Impact factor: 3.240

4.  Direct mitral regurgitation quantification in hypertrophic cardiomyopathy using 4D flow CMR jet tracking: evaluation in comparison to conventional CMR.

Authors:  Aakash N Gupta; Ryan Avery; Gilles Soulat; Bradley D Allen; Jeremy D Collins; Lubna Choudhury; Robert O Bonow; James Carr; Michael Markl; Mohammed S M Elbaz
Journal:  J Cardiovasc Magn Reson       Date:  2021-12-06       Impact factor: 5.364

5.  Papillary and Trabecular Muscles Have Substantial Impact on Quantification of Left Ventricle in Patients with Hypertrophic Obstructive Cardiomyopathy.

Authors:  Chengzhi Yang; Haobo Xu; Shubin Qiao; Ruofei Jia; Zening Jin; Jiansong Yuan
Journal:  Diagnostics (Basel)       Date:  2022-08-22

6.  Prognostic significance of cardiac magnetic resonance-based markers in patients with hypertrophic cardiomyopathy.

Authors:  Bela Merkely; Hajnalka Vago; Zsofia Dohy; Liliana Szabo; Attila Toth; Csilla Czimbalmos; Rebeka Horvath; Viktor Horvath; Ferenc Imre Suhai; Laszlo Geller
Journal:  Int J Cardiovasc Imaging       Date:  2021-02-08       Impact factor: 2.357

7.  Retrospective study of long-term outcomes of enzyme replacement therapy in Fabry disease: Analysis of prognostic factors.

Authors:  Maarten Arends; Marieke Biegstraaten; Derralynn A Hughes; Atul Mehta; Perry M Elliott; Daniel Oder; Oliver T Watkinson; Frédéric M Vaz; André B P van Kuilenburg; Christoph Wanner; Carla E M Hollak
Journal:  PLoS One       Date:  2017-08-01       Impact factor: 3.240

8.  Variation in left ventricular cardiac magnetic resonance normal reference ranges: systematic review and meta-analysis.

Authors:  Zahra Raisi-Estabragh; Asmaa A M Kenawy; Nay Aung; Jackie Cooper; Patricia B Munroe; Nicholas C Harvey; Steffen E Petersen; Mohammed Y Khanji
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2021-04-28       Impact factor: 6.875

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.